The future function and fortune of ovarian tissue which is retained in vivo during hysterectomy

B Ranney, Ranney B, Abu-Ghazaleh S, S Abu-Ghazaleh, Samir Abu-Ghazaleh
American journal of obstetrics and gynecology · 1977 · vol. 128(6) , pp. 626–634 · doi:10.1016/0002-9378(77)90208-3 · PMID:879222 · W1582378526
article OA: closed CC0 ⤵ 13 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-12 ⓘ

This paper reviews the future function and clinical outcomes of ovarian tissue intentionally left in place during hysterectomy procedures.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Hysterectomy was performed for 2,132 private patients; one third were done vaginally and two thirds, abdominally. Ages ranged from the 20's through the 80's, but 55% were between 40 and 55 years of age. Ovarian function was retained at the time of hysterectomy in 1,263 patients; ovarian tissue was retained in 1,557. Based on clinical criteria, 525 patients had continued ovarian function until last examined (one to 23 years); 328 had continued ovarian function until the end of the study (one to 25 years); 410 patients had cessation of ovarian function during the study at ages ranging from 41 to 64 years. Fourteen patients required second operations: three for hemorrhagic physiologic cysts, two for adhesions, one for ovarian endometriosis, four for cystadenomas, and four for ovarian cancer. Two cancer patients died; two are alive and well, five and 15 years after the second operations.

My notes (saved in your browser only)

MeSH descriptors

Hysterectomy Hysterectomy Ovary Adult Aged Climacteric Female Follow-Up Studies Humans Hysterectomy, Vaginal Hysterectomy, Vaginal Middle Aged Ovarian Cysts Ovarian Cysts Ovarian Neoplasms Ovarian Neoplasms Ovary Pelvis Postoperative Complications Time Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (13)

Source provenance

europepmc
last seen: 2026-07-31T06:09:14.520117+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:58:53.789372+00:00
License: CC0 · commercial use OK